MicroSectors Gold Miners -3X Inverse Leveraged ETNs

ProShares UltraShort Bloomberg Natrl Gas

ProShares UltraShort Silver

Bank Of Montreal

Direxion Daily Gold Miners Bear 3X ETF

VS TR 2x Long VIX Futures ETF

Direxion Daily Semicondct Bear 3X ETF

ProShares Ultra VIX Short-Term Futures

Direxion Technology Bear 3X Shares

ARK Innovation ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Silver

Direxion Daily Gold Miners Bull 3X ETF

United States Natural Gas

VanEck Vectors Junior Gold Miners ETF

Direxion Daily Semicondct Bull 3X ETF

iShares MSCI Japan

iShares Silver Trust

Direxion Daily Technology Bull 3X ETF

Kroger Company (The) Common Stock

RE/MAX Holdings Inc. Class A Common Stock

Gray Television Inc. Common Stock

Hims & Hers Health Inc. Class A Common Stock

Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)

Carvana Co. Class A Common Stock

Carter's Inc. Common Stock

ICL Group Ltd. Ordinary Shares

Lennar Corporation Class A Common Stock

Olin Corporation Common Stock

AgEagle Aerial Systems Inc. Common Stock

KBR Inc. Common Stock

Oklo Inc.

Cleveland-Cliffs Inc. Common Stock

Arista Networks Inc. Common Stock

Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)

MINISO Group Holding Limited American Depositary Shares each representing four Ordinary Shares

Endeavour Silver Corporation Ordinary Shares (Canada)

Unity Software Inc. Common Stock

Dutch Bros Inc. Class A Common Stock

Click here to get full coverage on Unicycive Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire

Unicycive Therapeutics, Inc. Announces Reverse Stock Split  GlobeNewswire

Unicycive Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire

Click here to get full coverage on Unicycive Sets 1-for-10 Reverse Split: What This Means for 126M Outstanding Shares - Stock Titan

Unicycive Sets 1-for-10 Reverse Split: What This Means for 126M Outstanding Shares  Stock Titan

Unicycive Sets 1-for-10 Reverse Split: What This Means for 126M Outstanding Shares - Stock Titan

Click here to get full coverage on Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - TipRanks

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?  TipRanks

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - TipRanks

Click here to get full coverage on Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation - Nasdaq

Click here to get full coverage on Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long - Yahoo Finance

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long  Yahoo Finance

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long - Yahoo Finance

Click here to get full coverage on Unicycive Therapeutics (UNCY) Trading Halted Amid Anticipated News | UNCY Stock News - GuruFocus

Unicycive Therapeutics (UNCY) Trading Halted Amid Anticipated News | UNCY Stock News  GuruFocus

Unicycive Therapeutics (UNCY) Trading Halted Amid Anticipated News | UNCY Stock News - GuruFocus

Click here to get full coverage on FDA Manufacturing Concerns Delay Unicycive's Crucial Kidney Disease Drug Approval Process - Stock Titan

FDA Manufacturing Concerns Delay Unicycive's Crucial Kidney Disease Drug Approval Process  Stock Titan

FDA Manufacturing Concerns Delay Unicycive's Crucial Kidney Disease Drug Approval Process - Stock Titan

Click here to get full coverage on Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - The Globe and Mail

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?  The Globe and Mail

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - The Globe and Mail

Click here to get full coverage on Unicycive Therapeutics Executes Reverse Stock Split - TipRanks

Unicycive Therapeutics Executes Reverse Stock Split  TipRanks

Unicycive Therapeutics Executes Reverse Stock Split - TipRanks

Click here to get full coverage on Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m - Yahoo Finance

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m  Yahoo Finance

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m - Yahoo Finance

Click here to get full coverage on Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update  GlobeNewswire

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates - Stock Titan

FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates  Stock Titan

FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates - Stock Titan

Click here to get full coverage on Unicycive Therapeutics (UNCY): HC Wainwright & Co. Sets Price Target | UNCY Stock News - GuruFocus

Unicycive Therapeutics (UNCY): HC Wainwright & Co. Sets Price Target | UNCY Stock News  GuruFocus

Unicycive Therapeutics (UNCY): HC Wainwright & Co. Sets Price Target | UNCY Stock News - GuruFocus

Click here to get full coverage on Unicycive Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire

Unicycive Therapeutics to Present at Upcoming Investor Conferences  GlobeNewswire

Unicycive Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Unicycive Reports Strong Q1 Results as Game-Changing Kidney Drug Nears FDA Decision Date - Stock Titan

Unicycive Reports Strong Q1 Results as Game-Changing Kidney Drug Nears FDA Decision Date  Stock Titan

Unicycive Reports Strong Q1 Results as Game-Changing Kidney Drug Nears FDA Decision Date - Stock Titan

Click here to get full coverage on Unicycive Therapeutics (UNCY) Announces 1-for-10 Reverse Stock S - GuruFocus

Unicycive Therapeutics (UNCY) Announces 1-for-10 Reverse Stock S  GuruFocus

Unicycive Therapeutics (UNCY) Announces 1-for-10 Reverse Stock S - GuruFocus

Click here to get full coverage on Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update  GlobeNewswire

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Updates Annual Meeting Schedule: Key Details for Kidney Disease Biotech Investors - Stock Titan

Unicycive Therapeutics Updates Annual Meeting Schedule: Key Details for Kidney Disease Biotech Investors  Stock Titan

Unicycive Therapeutics Updates Annual Meeting Schedule: Key Details for Kidney Disease Biotech Investors - Stock Titan

Click here to get full coverage on Unicycive Therapeutics Inc. (UNCY) reports earnings - Quartz

Unicycive Therapeutics Inc. (UNCY) reports earnings  Quartz

Unicycive Therapeutics Inc. (UNCY) reports earnings - Quartz

Click here to get full coverage on Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders - GlobeNewswire

Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders  GlobeNewswire

Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders - GlobeNewswire

Click here to get full coverage on Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY)  Yahoo Finance

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance

Click here to get full coverage on Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation - Yahoo Finance

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation  Yahoo Finance

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress - Stock Titan

Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress  Stock Titan

Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress - Stock Titan

Click here to get full coverage on Exclusive Look: Unicycive Unveils Latest Kidney Disease Breakthroughs at Major Healthcare Conference - Stock Titan

Exclusive Look: Unicycive Unveils Latest Kidney Disease Breakthroughs at Major Healthcare Conference  Stock Titan

Exclusive Look: Unicycive Unveils Latest Kidney Disease Breakthroughs at Major Healthcare Conference - Stock Titan

Click here to get full coverage on Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations - The Globe and Mail

Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations  The Globe and Mail

Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations - The Globe and Mail

Click here to get full coverage on Unicycive Therapeutics Announces Publication of Positive - GlobeNewswire

Unicycive Therapeutics Announces Publication of Positive  GlobeNewswire

Unicycive Therapeutics Announces Publication of Positive - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Is Expected To Breakeven In The Near Future - simplywall.st

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Is Expected To Breakeven In The Near Future  simplywall.st

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Is Expected To Breakeven In The Near Future - simplywall.st

Click here to get full coverage on Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference  GlobeNewswire

Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Announces the Publication of Patient - GlobeNewswire

Unicycive Therapeutics Announces the Publication of Patient  GlobeNewswire

Unicycive Therapeutics Announces the Publication of Patient - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Announces the Publication of - GlobeNewswire

Unicycive Therapeutics Announces the Publication of  GlobeNewswire

Unicycive Therapeutics Announces the Publication of - GlobeNewswire

Click here to get full coverage on Unicycive's OLC Drug Shows Strong Safety Profile in Phase 1 Trial, FDA Decision Due 2025 - Stock Titan

Unicycive's OLC Drug Shows Strong Safety Profile in Phase 1 Trial, FDA Decision Due 2025  Stock Titan

Unicycive's OLC Drug Shows Strong Safety Profile in Phase 1 Trial, FDA Decision Due 2025 - Stock Titan

Click here to get full coverage on Unicycive to Highlight Patient Reported Outcomes Data at - GlobeNewswire

Unicycive to Highlight Patient Reported Outcomes Data at  GlobeNewswire

Unicycive to Highlight Patient Reported Outcomes Data at - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics (UNCY) Receives Buy Rating with Promising Future | UNCY Stock News - GuruFocus

Unicycive Therapeutics (UNCY) Receives Buy Rating with Promising Future | UNCY Stock News  GuruFocus

Unicycive Therapeutics (UNCY) Receives Buy Rating with Promising Future | UNCY Stock News - GuruFocus

Click here to get full coverage on Unicycive Therapeutics Announces U.S. FDA Acceptance of the - GlobeNewswire

Unicycive Therapeutics Announces U.S. FDA Acceptance of the  GlobeNewswire

Unicycive Therapeutics Announces U.S. FDA Acceptance of the - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics to Participate in Two Upcoming - GlobeNewswire

Unicycive Therapeutics to Participate in Two Upcoming  GlobeNewswire

Unicycive Therapeutics to Participate in Two Upcoming - GlobeNewswire

Click here to get full coverage on Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update  GlobeNewswire

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics (UNCY) Alters 2025 Shareholder Meeting Ti - GuruFocus

Unicycive Therapeutics (UNCY) Alters 2025 Shareholder Meeting Ti  GuruFocus

Unicycive Therapeutics (UNCY) Alters 2025 Shareholder Meeting Ti - GuruFocus

Click here to get full coverage on Unicycive's Kidney Disease Drug Gets FDA Review Date, Aims for 2025 Launch - Stock Titan

Unicycive's Kidney Disease Drug Gets FDA Review Date, Aims for 2025 Launch  Stock Titan

Unicycive's Kidney Disease Drug Gets FDA Review Date, Aims for 2025 Launch - Stock Titan

Click here to get full coverage on Unicycive Therapeutics Updates Annual Meeting Time - TipRanks

Unicycive Therapeutics Updates Annual Meeting Time  TipRanks

Unicycive Therapeutics Updates Annual Meeting Time - TipRanks

Click here to get full coverage on Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers - GlobeNewswire

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers  GlobeNewswire

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics, Inc. SEC 10-Q Report - TradingView

Unicycive Therapeutics, Inc. SEC 10-Q Report  TradingView

Unicycive Therapeutics, Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on Unicycive Therapeutics announces 1-for-10 reverse stock split - TipRanks

Unicycive Therapeutics announces 1-for-10 reverse stock split  TipRanks

Unicycive Therapeutics announces 1-for-10 reverse stock split - TipRanks

Click here to get full coverage on Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis - GlobeNewswire

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis  GlobeNewswire

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024 - GlobeNewswire

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024  GlobeNewswire

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024 - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Faces FDA Compliance Delay - TipRanks

Unicycive Therapeutics Faces FDA Compliance Delay  TipRanks

Unicycive Therapeutics Faces FDA Compliance Delay - TipRanks

Click here to get full coverage on Unicycive Therapeutics granted extension to meet Nasdaq compliance - Investing.com

Unicycive Therapeutics granted extension to meet Nasdaq compliance  Investing.com

Unicycive Therapeutics granted extension to meet Nasdaq compliance - Investing.com

Click here to get full coverage on Benchmark maintains $3 target on Unicycive stock post-Q1 filings - Investing.com

Benchmark maintains $3 target on Unicycive stock post-Q1 filings  Investing.com

Benchmark maintains $3 target on Unicycive stock post-Q1 filings - Investing.com

Click here to get full coverage on Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On? - Benzinga

Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On?  Benzinga

Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On? - Benzinga

Click here to get full coverage on Benchmark maintains $3 target on Unicycive Therapeutics stock - Investing.com

Benchmark maintains $3 target on Unicycive Therapeutics stock  Investing.com

Benchmark maintains $3 target on Unicycive Therapeutics stock - Investing.com

Click here to get full coverage on H.C. Wainwright maintains Unicycive Buy rating, $7.50 target - Investing.com

H.C. Wainwright maintains Unicycive Buy rating, $7.50 target  Investing.com

H.C. Wainwright maintains Unicycive Buy rating, $7.50 target - Investing.com

Click here to get full coverage on Unicycive stock target raised to $7.50 by H.C. Wainwright - Investing.com

Unicycive stock target raised to $7.50 by H.C. Wainwright  Investing.com

Unicycive stock target raised to $7.50 by H.C. Wainwright - Investing.com

Click here to get full coverage on Unicycive to implement 1-for-10 reverse stock split to regain Nasdaq listing - Investing.com Nigeria

Unicycive to implement 1-for-10 reverse stock split to regain Nasdaq listing  Investing.com Nigeria

Unicycive to implement 1-for-10 reverse stock split to regain Nasdaq listing - Investing.com Nigeria

Click here to get full coverage on Unicycive drops after FDA finds drug manufacturing issues - Seeking Alpha

Unicycive drops after FDA finds drug manufacturing issues  Seeking Alpha

Unicycive drops after FDA finds drug manufacturing issues - Seeking Alpha

Click here to get full coverage on Unicycive Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - MarketScreener

Unicycive Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025  MarketScreener

Unicycive Therapeutics Inc (UNCY)

Price Chart

Key Statistics

Technicals

About UNCY

Latest News

Unicycive Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire

Unicycive Sets 1-for-10 Reverse Split: What This Means for 126M Outstanding Shares - Stock Titan

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - TipRanks

Advanced Charts

Top Gainers

Top Losers